These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24704326)

  • 1. The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats.
    Hachimine P; Seepersad N; Ananthan S; Ranaldi R
    Neurosci Lett; 2014 May; 569():137-41. PubMed ID: 24704326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference.
    Galaj E; Haynes J; Nisanov R; Ananthan S; Ranaldi R
    Drug Alcohol Depend; 2016 Feb; 159():263-6. PubMed ID: 26710978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.
    Galaj E; Manuszak M; Babic S; Ananthan S; Ranaldi R
    Drug Alcohol Depend; 2015 Nov; 156():228-233. PubMed ID: 26429728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats.
    Galaj E; Ananthan S; Saliba M; Ranaldi R
    Psychopharmacology (Berl); 2014 Feb; 231(3):501-10. PubMed ID: 24037509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Stepholidine blocks expression, but not development, of cocaine conditioned place preference in rats.
    Bennett A; Barrera E; Namballa H; Harding W; Ranaldi R
    Neurosci Lett; 2020 Aug; 734():135151. PubMed ID: 32531529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinjections of a dopamine D1 receptor antagonist into the ventral tegmental area block the expression of cocaine conditioned place preference in rats.
    Galaj E; Manuszak M; Arastehmanesh D; Ranaldi R
    Behav Brain Res; 2014 Oct; 272():279-85. PubMed ID: 25017572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective D₃ receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preference.
    Rice OV; Heidbreder CA; Gardner EL; Schonhar CD; Ashby CR
    Synapse; 2013 Aug; 67(8):469-75. PubMed ID: 23404528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective dopamine D₃ receptor antagonist SB-277011A attenuates drug- or food-deprivation reactivation of expression of conditioned place preference for cocaine in male Sprague-Dawley rats.
    Ashby CR; Rice OV; Heidbreder CA; Gardner EL
    Synapse; 2015 Jun; 69(6):336-44. PubMed ID: 25851636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D1 and D3 receptor interactions in cocaine reward and seeking in rats.
    Galaj E; Harding W; Ranaldi R
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3881-3890. PubMed ID: 27582181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.
    Vorel SR; Ashby CR; Paul M; Liu X; Hayes R; Hagan JJ; Middlemiss DN; Stemp G; Gardner EL
    J Neurosci; 2002 Nov; 22(21):9595-603. PubMed ID: 12417684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of stress- and cocaine prime-induced reinstatement of conditioned place preference after memory extinction through dopamine D3 receptor.
    Guerrero-Bautista R; Do Couto BR; Hidalgo JM; Cárceles-Moreno FJ; Molina G; Laorden ML; Núñez C; Milanés MV
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():308-320. PubMed ID: 30707990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of D2 dopamine receptors in oxytocin induced place preference and anxiolytic effect.
    László K; Péczely L; Géczi F; Kovács A; Zagoracz O; Ollmann T; Kertes E; Kállai V; László B; Berta B; Karádi Z; Lénárd L
    Horm Behav; 2020 Aug; 124():104777. PubMed ID: 32439347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP.
    Guerrero-Bautista R; Franco-García A; Hidalgo JM; Fernández-Gómez F; Milanés MV; Núñez C
    J Psychopharmacol; 2020 Nov; 34(11):1300-1315. PubMed ID: 32648812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine impairs acquisition and reinstatement of cocaine-induced place preference in rats.
    Barbosa-Méndez S; Matus-Ortega M; Jacinto-Gutiérrez S; Salazar-Juárez A
    Eur J Pharmacol; 2018 Feb; 820():183-190. PubMed ID: 29273459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Role of Dopamine in the PFC and NAc During Exposure to Cocaine-Associated Cues.
    Kawahara Y; Ohnishi YN; Ohnishi YH; Kawahara H; Nishi A
    Int J Neuropsychopharmacol; 2021 Dec; 24(12):988-1001. PubMed ID: 34626116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Dopaminergic Signaling in the Medial Prefrontal Cortex for the Expression of Cocaine-Induced Conditioned Place Preference in Rats.
    Shinohara F; Kamii H; Minami M; Kaneda K
    Biol Pharm Bull; 2017; 40(11):1983-1989. PubMed ID: 29093348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
    Gyertyán I; Gál K
    Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.
    Gilbert JG; Newman AH; Gardner EL; Ashby CR; Heidbreder CA; Pak AC; Peng XQ; Xi ZX
    Synapse; 2005 Jul; 57(1):17-28. PubMed ID: 15858839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D
    Reguilón MD; Montagud-Romero S; Ferrer-Pérez C; Roger-Sánchez C; Aguilar MA; Miñarro J; Rodríguez-Arias M
    Eur J Pharmacol; 2017 Mar; 799():48-57. PubMed ID: 28132915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.